It all starts with a cell, the basic unit of life. Within each cell are mitochondria, the working organelles that keep the cell full of energy and maintaining their growth and cycles. Working perfectly, we’re healthy and happy. It’s when the mitochondria begin to malfunction that the cells start to change, prompting a range of problems in the body.
Today’s health issues may actually be initiated from the energy producing processes of the basic unit of life, the cell. In plants and animals, including humans, the common component in energy producing processes is the mitochondria. As humans age the mitochondria begin to malfunction, making cell processes less and less effective. This, in turn, prompts a range of health problems typically associated with aging.
MitoGenetics has found therapeutic solutions for these mitochondrial and cellular changes and diseases – like type 2 diabetes, obesity, heart disease, hypertension, Alzheimer’s disease and Parkinson’s disease, to name a few – that have been linked to mitochondrial dysfunction. MitoGenetics uses a novel group of patented and patent-pending therapeutic products to manipulate mitochondria – rejuvenating and restoring the body to a healthy state. The possibilities are endless!
Additional research has led to the understanding of how MitoGenetics’ compounds affects the expression of genes and gene groups. This process has indicated positive effects on several beneficial gene groups that are related to positive therapeutic effects on several mitochondrial diseases.
MitoGenetics is looking for strategic partners from the pharmaceutical industry and venture capital that are excited about finding solutions.
Let us know if you are interested in learning more about us!
2329 North Career Avenue, Suite 316, Sioux Falls, SD 57107